These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 28715655)

  • 41. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides.
    Qian S; Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1491-508. PubMed ID: 25196358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elucidation of Exosome Migration across the Blood-Brain Barrier Model In Vitro.
    Chen CC; Liu L; Ma F; Wong CW; Guo XE; Chacko JV; Farhoodi HP; Zhang SX; Zimak J; Ségaliny A; Riazifar M; Pham V; Digman MA; Pone EJ; Zhao W
    Cell Mol Bioeng; 2016 Dec; 9(4):509-529. PubMed ID: 28392840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines.
    Gandomi N; Varshochian R; Atyabi F; Ghahremani MH; Sharifzadeh M; Amini M; Dinarvand R
    Pharm Dev Technol; 2017 May; 22(3):426-435. PubMed ID: 27575893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A fibrinogen-derived peptide provides intercellular adhesion molecule-1-specific targeting and intraendothelial transport of polymer nanocarriers in human cell cultures and mice.
    Garnacho C; Serrano D; Muro S
    J Pharmacol Exp Ther; 2012 Mar; 340(3):638-47. PubMed ID: 22160267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiological function and inflamed-brain migration of mouse monocyte-derived macrophages following cellular uptake of superparamagnetic iron oxide nanoparticles-Implication of macrophage-based drug delivery into the central nervous system.
    Tong HI; Kang W; Shi Y; Zhou G; Lu Y
    Int J Pharm; 2016 May; 505(1-2):271-82. PubMed ID: 27001531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28).
    Kuroda H; Tachikawa M; Yagi Y; Umetsu M; Nurdin A; Miyauchi E; Watanabe M; Uchida Y; Terasaki T
    Mol Pharm; 2019 Jan; 16(1):292-304. PubMed ID: 30452273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophages as Nanocarriers for Drug Delivery: Novel Therapeutics for Central Nervous System Diseases.
    Ye ZP; Ai XL; Faramand AM; Fang F
    J Nanosci Nanotechnol; 2018 Jan; 18(1):471-485. PubMed ID: 29768873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury.
    Wang C; Zhang C; Liu L; A X; Chen B; Li Y; Du J
    Mol Ther; 2017 Jan; 25(1):192-204. PubMed ID: 28129114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of nanocarrier-based CNS delivery systems.
    Tiwari SB; Amiji MM
    Curr Drug Deliv; 2006 Apr; 3(2):219-32. PubMed ID: 16611008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brain-Derived Neurotrophic Factor Inhibits Intercellular Adhesion Molecule-1 Expression in Interleukin-1β-Treated Endothelial Cells.
    Takeda K; Obinata Y; Konishi A; Kajiya M; Matsuda S; Mizuno N; Sasaki S; Fujita T; Kurihara H
    Cell Biochem Biophys; 2016 Sep; 74(3):399-406. PubMed ID: 27314517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation.
    Banks WA; Sharma P; Bullock KM; Hansen KM; Ludwig N; Whiteside TL
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system.
    Sobel RA; Mitchell ME; Fondren G
    Am J Pathol; 1990 Jun; 136(6):1309-16. PubMed ID: 1972610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanisms involved in T cell migration across the blood-brain barrier.
    Engelhardt B
    J Neural Transm (Vienna); 2006 Apr; 113(4):477-85. PubMed ID: 16550326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the blood-brain barrier for the delivery of stroke therapies.
    D'Souza A; Dave KM; Stetler RA; S Manickam D
    Adv Drug Deliv Rev; 2021 Apr; 171():332-351. PubMed ID: 33497734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
    Tran TH; Mattheolabakis G; Aldawsari H; Amiji M
    Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosomes are endogenous nanoparticles that can deliver biological information between cells.
    Sun D; Zhuang X; Zhang S; Deng ZB; Grizzle W; Miller D; Zhang HG
    Adv Drug Deliv Rev; 2013 Mar; 65(3):342-7. PubMed ID: 22776312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease.
    Qu M; Lin Q; Huang L; Fu Y; Wang L; He S; Fu Y; Yang S; Zhang Z; Zhang L; Sun X
    J Control Release; 2018 Oct; 287():156-166. PubMed ID: 30165139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.